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Abstract
Accompanying the dramatic increase in maternal obesity, the incidence of type I diabetes (T1D) in
children is also rapidly increasing. The objective of this study was to explore impacts of maternal
obesity on the incidence of T1D in offspring using non-obese diabetic (NOD) mice, a common
model for TID. Four-week-old female NOD mice were fed either a control diet (10% energy from
fat, CON) or a high fat diet (60% energy from fat, HFD) for 8 weeks before mating. Mice were
maintained in their respective diets during pregnancy and lactation. All offspring mice were fed
the control diet to 16 weeks. Female offspring (16-wk-old) born to obese dams showed more
severe islet lymphocyte infiltration (major manifestation of insulitis) (P < 0.01), concomitant with
elevated nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) p65 signaling (P
< 0.01) and tumor necrosis factor (TNF) α protein level (P < 0.05) in the pancreas. In addition,
maternal obesity resulted in impaired (P < 0.05) glucose tolerance and lower (P < 0.05) serum
insulin levels in offspring. In conclusion, maternal obesity resulted in exacerbated insulitis and
inflammation in the pancreas of NOD offspring mice, providing a possible explanation for the
increased incidence of T1D in children.
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Introduction
Obesity is rapidly increasing worldwide, with the current obesity rate in USA more than
35%. Accordingly, more than 30% of women aged 20–39 (child bearing age) are obese
(Ogden et al. 2012). Meanwhile, according to the statistics from American Autoimmune
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Related Diseases Association and National Institutes of Health, up to 23.5 million
Americans suffer from autoimmune disease and the prevalence is rising. Type I diabetes is
one of the major autoimmune diseases occurring in patients at young age, with about 30,000
diagnosed with Type 1 diabetes (T1D) annually (NIH autoimmune diseases statistics). The
prevalence rate in developed countries is increasing at around 3% per year (Gale 2002;
Sgouroudis and Piccirillo 2009).
Maternal obesity is considered as a risk factor for a number of adult diseases in offspring,
especially cardiovascular disease and type 2 diabetes, so called “developmental
programming” (Barker et al. 2002; Nathanielsz et al. 2007; Li et al. 2011; Portha et al.
2011; Poston 2012; Reynolds and Caton 2012). Recent epidemiological evidence indicates
that maternal nutrition is correlated with the risk of childhood T1D (D'Angeli et al. 2010).
T1D is an autoimmune disease caused by gradual pancreatic lymphocyte infiltration and the
destruction of insulin-producing β cells in the islets.
The etiology of T1D is complicated and multifactorial, including both genetic and
environmental risk factors. Epidemiological studies indicate that maternal intrauterine
environment and early postnatal nutrition are among environmental factors contributing to
the onset of T1D in children. Moreover, maternal over-nutrition or under-nutrition
predisposes offspring to metabolic disease syndromes by altering the development of less
vital organs such as the pancreas (Hales and Barker 2001; Harding 2001). Therefore,
intrauterine environment, birth weight and postnatal early life nutrition play a role in β cell
autoimmunity and are associated with a risk for T1D (Dahlquist et al. 1996; Kimpimaki et
al. 2002; Oge et al. 2007). Indeed, the pancreatic β cell function is altered in the fetuses of
obese sheep (Zhang et al. 2011). Maternal low protein diet, calorie restriction or neonatal
low protein exposure are associated with delayed T1D onset or decreased apoptosis of β
cells (Boujendar et al. 2002; Oge et al. 2007; Chamson-Reig et al. 2009). Though there is
recent epidemiological evidence supporting the association between maternal obesity and
T1D in offspring (D'Angeli et al. 2010), the possible causal relationship between maternal
obesity and increased risk of T1D in offspring has not been tested. Most available studies on
maternal obesity and offspring metabolic diseases focus on Type 2 diabetes (Barker et al.
2002; Yan et al. 2010). Non-obese diabetic (NOD) mice are susceptible to the spontaneous
development of T1D, with histological results showing peri-insulitis at 3 to 4 weeks of age
and severe insulitis by 10 weeks of age (Andre et al. 1996). Using NOD mice as an
experimental model, the aim of this study is to examine the effects of maternal obesity on
the onset of T1D in offspring.
Materials and methods
Animals and diet treatments
Forty three-week-old female NOD/ShiLtJ mice were obtained from the Jackson Laboratory
(Bar Harbor, ME). Mice were housed in a temperature-controlled room with a 12 h light: 12
h darkness cycle and were given food and water at ad libitum. At 4 weeks of age, mice were
randomly separated into two groups (n = 20 per group) and fed a control diet (CON, 19.2%
protein, 67.3% carbohydrate and 4.3% fat with 10% energy from fat; D12450B, Research
diet, New Brunswick, NJ) or a high fat diet (HFD, 26.2% protein, 26.3% carbohydrate and
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34.9% fat with 60% of energy from fat; D12492, Research diet) ad libitum, respectively for
8 weeks to induce obesity. These two diets mimick western “healthy” and “obesogenic”
diets respectively, and have been widely used for diet-induced obesity studies (Zhang et al.
1994). After inducing obesity, these female mice were mated with CON fed male mice of a
similar age. At birth, mice with abnormally large (above 8) or small litter sizes (less than 4)
were excluded. The size of remaining litters (n = 10 per treatment) were balanced to 6 pups
per litter by reducing large and increasing small litters. Maternal mice were maintained on
their respective CON or HFD diet during gestation and lactation. After weaning, all
offspring were fed with CON diet so that the only difference between treatments was the
maternal effect. The body weight and feed intake of both maternal and offspring mice were
measured weekly. Because female NOD mice are known to be more susceptible to the
development of T1D than male mice (Wicker et al. 1995), female offspring mice were
chosen for further analyses, to avoid the possible confounding effects of sex. All animal
procedures were approved by the Institutional Animal Use and Care Committee of
University of Wyoming.
Tissue collection
On the day of necropsy, after overnight fasting, one female mouse with average body weight
from each litter was selected. These mice were anesthetized intraperitoneally with
tribromoethanol (250 mg/kg body weight). Blood samples were collected under anesthesia,
and serum was used for insulin analysis. Mice were sacrificed by cervical dislocation, the
pancreas was removed, and a small portion of the pancreas from each mouse was fixed in
4% (w/v) paraformaldehyde dissolved in phosphate buffer (0.12 M; pH 7.4), processed and
embedded into paraffin per standard methods. The remaining pancreatic tissue was frozen in
liquid nitrogen, and stored at −80 °C for further biochemical analyses. In addition, the
gonadal fat was collected and weighed, because gonadal fat weight is highly correlated with
adiposity in mice (Rogers and Webb 1980).
Insulitis scoring
The paraffin embedded pancreatic tissues were sectioned at 5 µm thickness. Sections were
collected at 50 µm interval, subjected to hematoxylin-eosin staining (HE) for evaluation of
insulitis (lymphocyte infiltration) using the following scale: 0, no infiltration; 1, minimal
focal infiltration; 2 peri-islet infiltration (<25%); 3, intra-islet infiltration (25<50%); 4,
extensive infiltration (>50%). The mean insulitis score of each offspring was calculated by
dividing the sum of the insulitis scores by the number of islets examined. At least 20 islets
per animal were analyzed by two independent examiners in a blind manner.
Intraperitoneal glucose tolerance test
Following 8-week treatment maternal NOD mice with CON or HFD diet (n = 20 per dietary
group), or female offspring mice at age of 16 week (one mouse per litter of average body
weight) were subjected to intraperitoneal (i.p.) glucose tolerance tests after overnight fasting
with free access to water. Glucose was injected i.p. into mice at 2 g/kg body weight. Glucose
concentrations of each mouse were measured with a glucometer (Bayer’s Contour,
Tarrytown, NY) at 0, 15, 30, 60, 90 and 120 min after injection using blood collected from
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the tail vein. The glucose level of mice within dietary treatment at each time point post
injection was averaged and graphed against time post injection. The total area under the
glucose disposal curve (AUC) was calculated for each animal with GraphPad Prism 5.0
software without subtracting the baseline, and means computed. Glucose levels at each time
point were analyzed by Repeated Measures ANOVA, and AUC was analyzed by ANOVA.
Insulin analysis
After overnight fasting, blood serum samples collected at necropsy day were used for insulin
analysis. Serum insulin concentration was determined in duplicate in a single assay by
commercial ELISA kit (Linco Research Inc., St. Charles, MO, USA) according to the
manufacturer’s instructions. Mean intra-assay and inter-assay CV for insulin was < 10%.
Immunoblotting analyses
Immunoblotting analysis was conducted as previously described (Zhu et al. 2010; Yan et al.
2011). Antibodies against phospho-NF-κB p65 (Ser536), NF-κB p65, phospho-Akt
(Ser473), and Akt were purchased from Cell Signaling Technology (Beverly, MA). Tumor
necrosis factor (TNF) α antibody was purchased from Invitrogen (Grand Island, NY), while
β-actin antibody was purchased from Sigma (St. Louis, MO). Density of bands was
normalized with reference to the β-actin content.
Statistical Analysis
Data were analyzed as a complete randomized design using GLM (General Linear Model of
Statistical Analysis System, SAS, 2000). For GTT, glucose levels at different time points
were analyzed as repeated measures ANOVA using SAS Proc Mixed. Each maternal mouse
and the subsequent litter was considered as an experimental unit. Means ± standard errors of
mean (SEM) are reported. The differences between group means were analyzed by
ANOVA. Statistical significance is considered as P < 0.05.
Results
High fat diet leading to obese phenotype in NOD mice
During 8 weeks of dietary treatment, the overall feed intake was similar between CON and
HFD fed maternal NOD mice (Fig. 1A). Starting the first week of feeding, maternal NOD
mice fed with HFD gained more body weight than those fed the CON diet (Fig. 1B, P <
0.01). After 8 weeks of dietary treatment, HFD fed mice developed obesity with more
gonadal fat (Fig. 1C & D). The fasting baseline blood glucose level were higher (Fig. 1E, P
< 0.05) in NOD mice fed with HFD than those in CON fed mice at 4 weeks of dietary
treatments. Although the fasting baseline blood glucose was similar, the HFD fed mice had
impaired glucose tolerance compared to those fed CON diet after 8 weeks of dietary
treatments (Fig. 1F, P < 0.01).
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Body weight of female NOD offspring
Offspring born to CON and HFD fed dam had similar food intake and body weight (Fig.
2AB). The ratios of heart (P < 0.05) weight to offspring body weight were higher in female
offspring exposed to maternal obesity (Fig. 2C).
Offspring from HFD dams developed more severe insulitis
Fig. 3A illustrates the histological scoring system that was used to evaluate effects of
maternal obesity on pancreatic insulitis of female offspring. As shown in Fig. 3B & C, the
female offspring exposed to maternal HFD showed more severe (P < 0.05) insulitis than
those from CON dams.
Pancreatic inflammatory signaling pathways in female offspring
Consistent with more severe lymphocyte infiltration, the major mediator of inflammatory
NF-κB signaling, phos-p65, was elevated (P< 0.01) in pancreatic tissue of offspring from
HFD fed dams (Fig. 4A), suggesting an exaggerated pancreatic inflammatory response.
Accordingly, higher TNFα protein level was also detected in pancreatic tissue of offspring
born to HFD fed dams (Fig. 4B, P < 0.05).
Insulin signaling in female offspring
Although the intraperitoneal glucose tolerance test at 16 weeks of age revealed relatively
minor differences, the area under curve (AUC) was greater (Fig. 5A, P < 0.05) in offspring
from HFD fed dams, suggesting impaired glucose tolerance. This could be related to the
trend of reduction of phos-Akt in pancreas tissue of offspring from HFD fed dam (Fig. 5B, P
< 0.10). Conversely, offspring born from HFD fed dams had lower (P < 0.05) serum insulin
level compared to those from CON fed dam (Fig. 5C), indicating decreased insulin
production which could also explain the impaired glucose tolerance.
Discussion
While limited studies have shown that maternal obesity impairs fetal pancreatic β-cell
development and postnatal function (Han et al. 2005; Ford et al. 2009; Zhang et al. 2011),
the relationship between maternal obesity and the onset of T1D in offspring remains unclear.
To clarify this relationship, we induced obesity in NOD mice to test whether maternal
obesity predisposes offspring to T1D. NOD mice are prone to develop TID and are the most
frequently used model for studying this disease. Wild-type mice were not used here because
their incidence of TID is too low. In addition to obesity, NOD maternal mice had an
elevated fasting blood glucose level after 4 weeks of HFD treatment and impaired glucose
tolerance after 8 weeks. Together, these maternal mice were obese, with elevated blood
glucose and impaired glucose tolerance, similar to obese human mothers.
Maternal obesity accelerates the development of T1D in offspring mice. We observed severe
lymphocyte infiltration in the pancreatic islets of offspring exposed to maternal obesity,
showing the increased degree of insulitis. Consistent with lymphocyte infiltration data,
pancreatic tissue in offspring from HFD fed dam had augmented TNF-α content, and
heightened inflammatory NF-κB signaling as indicated by elevated p65 activation. These
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data are in line with previous reports, where maternal obesity elevates cytokines and
inflammatory signaling in other tissues of fetuses and offspring (White et al. 2008; Bilbo
and Tsang 2010; Leibowitz et al. 2012). The observed inflammatory responses in offspring
pancreatic tissue from obese dams might be a contributing factor to their exaggerated
insulitis (Kurylowicz and Nauman 2008; Thomas et al. 2012). Cytokines (IL1β, TNF-α and
IFN-γ) can induce β cell stress leading to apoptosis in human and rodent T1D models by
increasing the expression of pro-apoptotic proteins (Rabinovitch 1998; Rabinovitch and
Suarez-Pinzon 1998; Pavlovic et al. 2000; Petrovsky et al. 2002). Our data are in line with a
previous report, where maternal obesity resulted in pancreatic dysfunction in offspring and
was associated with the development of T2D. However, in that study, the possible link of
maternal obesity to T1D was not studied or discussed (Han et al. 2005). Consistent with our
observations, maternal calorie restriction and low maternal nutrition has been shown to
delay onset of T1D (Oge et al. 2007; Chamson-Reig et al. 2009).
We also detected glucose intolerance in maternal obesity offspring, which coincided with
lower insulin levels. Akt activation contributes to insulin sensitivity in peripheral organs and
also could suppress stress induced β cells death (Leibiger et al. 2008). We observed a
tendency of decreased Akt phosphorylation in pancreas of maternal obesity offspring. This
down-regulated Akt signaling in pancreas might further accelerate pancreatic cell apoptosis.
In summary, maternal obesity resulted in exaggerated insulitis, impaired glucose tolerance
and reduced baseline insulin in female NOD offspring by 16 weeks of age. The mechanism
for accelerated onset of T1D due to maternal obesity might be associated with augmented
inflammation in the offspring pancreas. Up to now, the impact of maternal obesity on
offspring metabolic diseases has been focused on T2D. To our knowledge, this is the first
report showing that maternal obesity predisposes offspring to T1D, which is an important
addition to our understanding regarding the long-term programming effects of maternal
obesity on offspring health. Considering that more than 30% pregnant women are obese, the
current finding has important clinical implications.
Acknowledgments
The authors gratefully acknowledged Dr. Joseph R. Powers in the School of Food School at Washington State
University for his critical review on the manuscript, and Mr. David Hanna in the Department of Animal Science at
University of Wyoming for taking care of mice and facilitate experiments.
Funding
Funding was supported by NIH R15HD073864 and NIH INBRE P20RR016474.
References
Andre I, Gonzalez A, Wang B, Katz J, Benoist C, Mathis D. Checkpoints in the progression of
autoimmune disease: lessons from diabetes models. Proc Natl Acad Sci U S A. 1996; 93(6):2260–
2263. [PubMed: 8637860]
Barker DJ, Eriksson JG, Forsen T, Osmond C. Fetal origins of adult disease: strength of effects and
biological basis. Int J Epidemiol. 2002; 31(6):1235–1239. [PubMed: 12540728]
Bilbo SD, Tsang V. Enduring consequences of maternal obesity for brain inflammation and behavior
of offspring. Faseb Journal. 2010; 24(6):2104–2115. [PubMed: 20124437]
Wang et al. Page 6






















Boujendar S, Reusens B, Merezak S, Ahn MT, Arany E, Hill D, Remacle C. Taurine supplementation
to a low protein diet during foetal and early postnatal life restores a normal proliferation and
apoptosis of rat pancreatic islets. Diabetologia. 2002; 45(6):856–866. [PubMed: 12107730]
Chamson-Reig A, Arany EJ, Summers K, Hill DJ. A low protein diet in early life delays the onset of
diabetes in the non-obese diabetic mouse. J Endocrinol. 2009; 201(2):231–239. [PubMed:
19228796]
D'Angeli MA, Merzon E, Valbuena LF, Tirschwell D, Paris CA, Mueller BA. Environmental factors
associated with childhood-onset type 1 diabetes mellitus: an exploration of the hygiene and
overload hypotheses. Arch Pediatr Adolesc Med. 2010; 164(8):732–738. [PubMed: 20679164]
Dahlquist G, Bennich SS, Kallen B. Intrauterine growth pattern and risk of childhood onset insulin
dependent (type I) diabetes: population based case-control study. BMJ. 1996; 313(7066):1174–
1177. [PubMed: 8916747]
Ford SP, Zhang L, Zhu M, Miller MM, Smith DT, Hess BW, Moss GE, Nathanielsz PW, Nijland MJ.
Maternal obesity accelerates fetal pancreatic beta-cell but not alpha-cell development in sheep:
prenatal consequences. Am J Physiol Regul Integr Comp Physiol. 2009; 297(3):R835–R843.
[PubMed: 19605766]
Gale EA. The rise of childhood type 1 diabetes in the 20th century. Diabetes. 2002; 51(12):3353–3361.
[PubMed: 12453886]
Hales CN, Barker DJ. The thrifty phenotype hypothesis. Br Med Bull. 2001; 60:5–20. [PubMed:
11809615]
Han J, Xu J, Epstein PN, Liu YQ. Long-term effect of maternal obesity on pancreatic beta cells of
offspring: reduced beta cell adaptation to high glucose and high-fat diet challenges in adult female
mouse offspring. Diabetologia. 2005; 48(9):1810–1818. [PubMed: 16010523]
Harding JE. The nutritional basis of the fetal origins of adult disease. Int J Epidemiol. 2001; 30(1):15–
23. [PubMed: 11171842]
Kimpimaki T, Kulmala P, Savola K, Kupila A, Korhonen S, Simell T, Ilonen J, Simell O, Knip M.
Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility
to type 1 diabetes recruited from the general population. J Clin Endocrinol Metab. 2002; 87(10):
4572–4579. [PubMed: 12364437]
Kurylowicz A, Nauman J. The role of nuclear factor-kappaB in the development of autoimmune
diseases: a link between genes and environment. Acta Biochim Pol. 2008; 55(4):629–647.
[PubMed: 19081854]
Leibiger IB, Leibiger B, Berggren PO. Insulin signaling in the pancreatic beta-cell. Annu Rev Nutr.
2008; 28:233–251. [PubMed: 18481923]
Leibowitz KL, Moore RH, Ahima RS, Stunkard AJ, Stallings VA, Berkowitz RI, Chittams JL, Faith
MS, Stettler N. Maternal obesity associated with inflammation in their children. World Journal of
Pediatrics. 2012; 8(1):76–79. [PubMed: 21874618]
Li M, Sloboda DM, Vickers MH. Maternal obesity and developmental programming of metabolic
disorders in offspring: evidence from animal models. Exp Diabetes Res. 2011; 2011:592408.
[PubMed: 21969822]
Nathanielsz PW, Poston L, Taylor PD. In utero exposure to maternal obesity and diabetes: animal
models that identify and characterize implications for future health. Clin Perinatol. 2007; 34(4):
515–526. [PubMed: 18063102]
Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity in the United States, 2009–2010.
NCHS Data Brief. 2012; (82):1–8.
Oge A, Isganaitis E, Jimenez-Chillaron J, Reamer C, Faucette R, Barry K, Przybyla R, Patti ME. In
utero undernutrition reduces diabetes incidence in non-obese diabetic mice. Diabetologia. 2007;
50(5):1099–1108. [PubMed: 17370059]
Pavlovic D, Andersen NA, Mandrup-Poulsen T, Eizirik DL. Activation of extracellular signal-
regulated kinase (ERK)1/2 contributes to cytokine-induced apoptosis in purified rat pancreatic
beta-cells. Eur Cytokine Netw. 2000; 11(2):267–274. [PubMed: 10903806]
Petrovsky N, Silva D, Socha L, Slattery R, Charlton B. The role of Fas ligand in beta cell destruction
in autoimmune diabetes of NOD mice. Ann N Y Acad Sci. 2002; 958:204–208. [PubMed:
12021107]
Wang et al. Page 7






















Portha B, Chavey A, Movassat J. Early-life origins of type 2 diabetes: fetal programming of the beta-
cell mass. Exp Diabetes Res. 2011; 2011:105076. [PubMed: 22110471]
Poston L. Maternal obesity, gestational weight gain and diet as determinants of offspring long term
health. Best Pract Res Clin Endocrinol Metab. 2012; 26(5):627–639. [PubMed: 22980045]
Rabinovitch A. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus.
Diabetes Metab Rev. 1998; 14(2):129–151. [PubMed: 9679667]
Rabinovitch A, Suarez-Pinzon WL. Cytokines and their roles in pancreatic islet beta-cell destruction
and insulin-dependent diabetes mellitus. Biochem Pharmacol. 1998; 55(8):1139–1149. [PubMed:
9719467]
Reynolds LP, Caton JS. Role of the pre- and post-natal environment in developmental programming of
health and productivity. Mol Cell Endocrinol. 2012; 354(1-2):54–59. [PubMed: 22154989]
Rogers P, Webb GP. Estimation of body fat in normal and obese mice. Br J Nutr. 1980; 43(1):83–86.
[PubMed: 7370219]
Sgouroudis E, Piccirillo CA. Control of type 1 diabetes by CD4+Foxp3+ regulatory T cells: lessons
from mouse models and implications for human disease. Diabetes Metab Res Rev. 2009; 25(3):
208–218. [PubMed: 19214972]
Thomas HE, Graham KL, Chee J, Thomas R, Kay TW, Krishnamurthy B. Proinflammatory cytokines
contribute to development and function of regulatory T cells in type 1 diabetes. Ann N Y Acad
Sci. 2012
White C, Purpera M, Morrison C. Maternal Adiposity Predisposes Offspring to Obesity Independent of
Maternal Diet. Obesity. 2008; 16:S74–S74.
Wicker LS, Todd JA, Peterson LB. Genetic control of autoimmune diabetes in the NOD mouse. Annu
Rev Immunol. 1995; 13:179–200. [PubMed: 7612220]
Yan X, Huang Y, Wang H, Du M, Hess BW, Ford SP, Nathanielsz PW, Zhu MJ. Maternal obesity
induces sustained inflammation in both fetal and offspring large intestine of sheep. Inflamm Bowel
Dis. 2011; 17(7):1513–1522. [PubMed: 21674707]
Yan X, Zhu MJ, Xu W, Tong JF, Ford SP, Nathanielsz PW, Du M. Up-regulation of Toll-like receptor
4/nuclear factor-kappaB signaling is associated with enhanced adipogenesis and insulin resistance
in fetal skeletal muscle of obese sheep at late gestation. Endocrinology. 2010; 151(1):380–387.
[PubMed: 19887565]
Zhang L, Long NM, Hein SM, Ma Y, Nathanielsz PW, Ford SP. Maternal obesity in ewes results in
reduced fetal pancreatic beta-cell numbers in late gestation and decreased circulating insulin
concentration at term. Domest Anim Endocrinol. 2011; 40(1):30–39. [PubMed: 20933362]
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse
obese gene and its human homologue. Nature. 1994; 372(6505):425–432. [PubMed: 7984236]
Zhu MJ, Du M, Nathanielsz PW, Ford SP. Maternal obesity up-regulates inflammatory signaling
pathways and enhances cytokine expression in the mid-gestation sheep placenta. Placenta. 2010;
31(5):387–391. [PubMed: 20185176]
Wang et al. Page 8























High fat diet (HFD) induced obese phenotypes in maternal NOD mice. A: Weekly feed
intake; B: Weekly body weight; C: Representative images of fat tissue in maternal NOD
mice of CON and HFD treatments at necropsy; D: Gonadal fat weight at necropsy; E: Base
line blood glucose concentration of maternal NOD mice following 4 or 8 weeks of CON or
HFD diet; F: Intraperitoneal glucose tolerance test of maternal NOD mice following 8 weeks
of CON or HFD treatment. Glucose was injected i.p. at 2 g/kg body weight. Blood glucose
concentrations were measured at 0, 15, 30, 60, 90, and 120 min post glucose injection.
(Mean ± SEM; **: P < 0.01,*: P < 0.05; N = 20).
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Effects of maternal obesity on female offspring (16-week-old) feed intake, and body, organ
and tissue weights. A: Offspring weekly feed intake; B: Offspring weekly body weight; C:
Organ weights normalized as a percentage of total body weight. (Mean ± SEM; *: P < 0.05;
#: P < 0.10; N = 10).
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Pancreatic pathobiological changes of female offspring mice (16-week-old) exposed to
maternal CON or HFD diet. The paraffin embedded pancreatic tissues were sectioned at 5
µm thickness, and subjected to hematoxylin-eosin staining. A: Insulitis (lymphocyte
infiltration in the islet of pancreas) scoring system; B: Pancreatic insulitis score; C:
Representative images of pancreatic islets of CON and HFD offspring. (Mean ± SEM; **: P
< 0.01; N = 10)
Wang et al. Page 11























Inflammatory signaling (A) and inflammatory cytokine content (B) in pancreas tissues of
female offspring (16-week-old) exposed to maternal CON (□) or HFD (■) diet. Pancreatic
tissues were subjected to immunoblotting. A: Elevation of NF-κB signaling shown by
increased ratio of p-p65 to p65 level in HFD compared to CON offspring pancreas; B:
Enhanced TNF-α protein level in HFD compared to CON offspring pancreas. (Mean ±
SEM; **: P < 0.01; *: P < 0.05; N = 10)
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Intraperitoneal glucose tolerance and insulin signaling of the pancreas of female offspring
(16-week-old) exposed to maternal CON (□) or HFD (■) diet. A: Intraperitoneal glucose
tolerance test with area under curve (AUC). Glucose was injected i.p. at 2 g/kg body weight.
Blood glucose concentrations were measured at 0, 15, 30, 60, 90, and 120 min after glucose
injection; B: Pancreatic phos-Akt and total Akt levels measured by immunoblotting; C.
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Fasting blood serum insulin level. (Mean ± SEM; **: P < 0.01; *: P < 0.05; #: P < 0.10; N =
10)
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